ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Cancer Immunology and Immunotherapy
Immuno-Oncology
Latest ESMO videos
Featured medwireNews
Stage III High-Risk Melanoma Benefits With Dabrafenib–Trametinib, Pembrolizumab
Pembrolizumab Plus Innate Immune Activator May Benefit Metastatic TNBC Patients
IMbassador250 Rules Out Atezolizumab For Metastatic CRPC
Durvalumab May Be ‘Feasible’ For HIV-Positive Cancer Patients
Adding Pembrolizumab To Docetaxel Improves Second-Line NSCLC Outcomes
E-Learning
ESMO E-Learning: Immunotherapy Strategies for Colorectal Cancer
ESMO E-Learning: Next Generation Drugs in Kidney Cancer
ESMO E-Learning: New Treatments in Melanoma
ESMO E-Learning: Future Directions in Clinical Research of NSCLC
Factsheets on Biomarkers
Tumour Mutational Load: ESMO Biomarker Factsheet
Meeting resources
ESMO Congress
ESMO Immuno-Oncology Congress 2019
Geneva
ESMO Congress
ESMO Asia Congress 2019
Singapore
ESMO Course
ESMO Preceptorship on Immuno-Oncology Singapore November 2019
Singapore
ESMO Congress
ESMO Congress 2019
Barcelona
ESMO Course
ESMO Advanced Course on Immunotherapy in Lung Cancer July 2019
Zurich